Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a medical device company that develops, manufactures and markets surgical products, many of which are based on our minimally invasive patented Coblation® technology. We seek to capitalize on market opportunities across several medical specialties, improve many existing soft-tissue surgical procedures and enable new minimally invasive procedures. Our innovative technologies improve the lives of individuals as diverse as world class athletes suffering from torn rotator cuffs to senior citizens suffering from herniated discs and children suffering from tonsillitis. We incorporated in California in 1993 and reincorporated in Delaware in 1995. Our objective is to expand on our position as a leading global provider of minimally invasive surgical products. We seek to differentiate ourselves in this competitive market by providing our patients and user-physicians with improved treatment options. ... More ...
Analyst Info |
|
| Annual EPS Est: | $1.25 |
| Quarterly EPS Est: | 0.35 |
| PEG Ratio: | 1.61 |
|
Mean Recommendation: View Summary / View All |
1.67 |
Data is provided by Zacks Investment Research
